Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Plasma after both SARS-CoV-2 boosted vaccination and COVID-19 potently neutralizes BQ.1.1 and XBB.1
David J. Sullivan, Massimo Franchini, Jonathon W. Senefeld, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 17

Showing 17 citing articles:

Convergent Evolution in SARS-CoV-2 Spike Creates a Variant Soup from Which New COVID-19 Waves Emerge
Daniele Focosi, Rodrigo Quiroga, Scott A. McConnell, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2264-2264
Open Access | Times Cited: 114
SARS-CoV-2 variants resistant to monoclonal antibodies in immunocompromised patients constitute a public health concern
Arturo Casadevall, Daniele Focosi
Journal of Clinical Investigation (2023) Vol. 133, Iss. 6
Open Access | Times Cited: 31
SARS-CoV-2 BA.2.86 (“Pirola”): Is it Pi or Just Another Omicron Sublineage?
Daniele Focosi, Pietro Giorgio Spezia, Fabrizio Maggi
Vaccines (2023) Vol. 11, Iss. 11, pp. 1634-1634
Open Access | Times Cited: 13
WHO Is Recommending against the Use of COVID-19 Convalescent Plasma in Immunocompromised Patients?
Massimo Franchini, Arturo Casadevall, Michael J. Joyner, et al.
Life (2023) Vol. 13, Iss. 1, pp. 134-134
Open Access | Times Cited: 8
The re-emergence of COVID-19 in China is a big threat for the world: Associated risk factors and preventive measures
Sampa Barai, Mohammad Fahim Kadir, Mohammad Shahriar, et al.
Annals of Medicine and Surgery (2023) Vol. 85, Iss. 2, pp. 348-350
Open Access | Times Cited: 6
Rational prediction of immunogenicity clustering through cross‐reactivity analysis of thirteen SARS‐CoV‐2 variants
Ziteng Liang, Jincheng Tong, Ziqi Sun, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 1
Closed Access | Times Cited: 1
Monoclonal Antibody Therapies Against SARS-CoV-2: Promises and Realities
Daniele Focosi
Current topics in microbiology and immunology (2024)
Closed Access | Times Cited: 1
Serum anti‐Spike immunoglobulin G levels in random blood donors in Italy: High‐titre convalescent plasma is easier than ever to procure
Daniele Focosi, Silvia Meschi, Sabrina Coen, et al.
Vox Sanguinis (2023) Vol. 118, Iss. 9, pp. 794-797
Closed Access | Times Cited: 4
Convergent evolution in SARS-CoV-2 Spike creates a variant soup that causes new COVID-19 waves
Daniele Focosi, Rodrigo Quiroga, Scott A. McConnell, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 7
High‐titer post‐vaccine COVID‐19 convalescent plasma for immunocompromised patients during the first omicron surge
Ralph Tayyar, Lisa Wong, Alex Dahlen, et al.
Transplant Infectious Disease (2023) Vol. 25, Iss. 2
Open Access | Times Cited: 3
Clinical Virology and Effect of Vaccination and Monoclonal Antibodies against SARS-CoV-2 Omicron Sub Variant BF.7 (BA.5.2.1.7): A systematic review
Santenna Chenchula, Krishna Chaitanya Amerneni, Mohan Krishna Ghanta, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 6
A Simple Epidemiologic Model for Predicting Impaired Neutralization of New SARS-CoV-2 Variants
Giuseppe Lippi, Brandon Michael Henry, Mario Plebani
Vaccines (2023) Vol. 11, Iss. 1, pp. 128-128
Open Access | Times Cited: 2
Poor neutralizing antibody responses against SARS-CoV-2 Omicron BQ.1.1 and XBB in Norway in October 2022
Elisabeth Lea Vikse, Even Fossum, Magnhild Sekse Erdal, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
COVID-19 convalescent plasma retains value for immunocompromised patients
Daniele Focosi, Massimo Franchini
Leukemia (2023) Vol. 37, Iss. 8, pp. 1762-1763
Closed Access | Times Cited: 2
Convalescent plasma for COVID-19 in oncohematological patients: a call for revision of the European Conference on Infections in Leukemia-9 (ECIL-9) guidelines
Daniele Focosi, Massimo Franchini, Jonathon W. Senefeld, et al.
Journal of Clinical Virology Plus (2022) Vol. 3, Iss. 1, pp. 100128-100128
Open Access | Times Cited: 4
SARS-CoV-2: Advances in Serological Methods and the Understanding of Antibody Escape
Daniele Focosi, Fabrizio Maggi
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2488-2488
Open Access
In the Literature
Stan Deresinski
Clinical Infectious Diseases (2023) Vol. 76, Iss. 7, pp. i-ii
Open Access
Page 1

Scroll to top